SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001694665-23-000059
Filing Date
2023-05-15
Accepted
2023-05-15 16:43:32
Documents
67
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q evlo-20230331.htm   iXBRL 10-Q 1319206
2 EX-31.1 exhibit311ceo302certificat.htm EX-31.1 13584
3 EX-31.2 exhibit312cfo302certificat.htm EX-31.2 13609
4 EX-32.1 exhibit321ceo906certificat.htm EX-32.1 8195
5 EX-32.2 exhibit322cfo906certificat.htm EX-32.2 7553
11 evlo-20230331_g1.jpg GRAPHIC 7885
  Complete submission text file 0001694665-23-000059.txt   5578437

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evlo-20230331.xsd EX-101.SCH 38000
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT evlo-20230331_cal.xml EX-101.CAL 50180
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evlo-20230331_def.xml EX-101.DEF 161969
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evlo-20230331_lab.xml EX-101.LAB 527701
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evlo-20230331_pre.xml EX-101.PRE 319520
61 EXTRACTED XBRL INSTANCE DOCUMENT evlo-20230331_htm.xml XML 689734
Mailing Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139 617-577-0300
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38473 | Film No.: 23923521
SIC: 2834 Pharmaceutical Preparations